← Browse by Condition
Medical Condition

grade 3a follicular lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06948786 Phase 2
Recruiting

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

Enrollment
22 pts
Location
United States
Sponsor
University of Washington
View Trial →